Viera Muzithras
Conseiller Juridique Général chez TCR2 THERAPEUTICS INC.
Profil
Viera Muzithras is currently the Vice President-Regulatory Affairs at TCR2 Therapeutics, Inc. Prior to this, he worked as an Executive Director-Global Regulatory Affairs at Bristol Myers Squibb Co. and as a Senior Director-Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2008 to 2016.
He obtained his undergraduate degree from Rutgers State University of New Jersey.
Postes actifs de Viera Muzithras
| Sociétés | Poste | Début |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Conseiller Juridique Général | 27/05/2020 |
Anciens postes connus de Viera Muzithras
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Public Communications Contact | 01/07/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Conseiller Juridique Général | - |
Formation de Viera Muzithras
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |